Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy

The invention relates to human medicine and to the use of epidermal growth factor (EGF) for preparing a pharmaceutical composition which is administered by infiltration into the periphery of nerve ganglia and/or trunks for the morphofunctional restoration of peripheral nerves in painful sensory-moto...

Full description

Saved in:
Bibliographic Details
Main Authors HERRERA MARTINEZ LUIS SATURNINO, CIBRIAN VERA DANAY, SAEZ MARTINEZ VIVIAN MARIA, FERNANDEZ MONTEQUIN JOSE IGNACIO, UBIETA GOMEZ RAIMUNDO, GONZALEZ BLANCO SONIA, BERLANGA ACOSTA JORGE AMADOR, GUILLEN NIETO GERARDO ENRIQUE, GARCIA DEL BARCO HERRERA DIANA
Format Patent
LanguageEnglish
Published 04.02.2014
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to human medicine and to the use of epidermal growth factor (EGF) for preparing a pharmaceutical composition which is administered by infiltration into the periphery of nerve ganglia and/or trunks for the morphofunctional restoration of peripheral nerves in painful sensory-motor neuropathy as well as manifestations of ischemic neuritis. The invention also includes a composition containing EGF which can be formulated together with anesthetics or analgesics or encapsulated in microspheres and to the use thereof for the morphofunctional restoration of peripheral nerves in painful sensitive-motor-type diabetic neuropathy and the manifestations of ischemic neuritis.
Bibliography:Application Number: US20070443837